About HTG Molecular Diagnostics
HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: HTGM
- Previous Close: $1.23
- 50 Day Moving Average: $1.84
- 200 Day Moving Average: $2.19
- 52-Week Range: $1.20 - $4.45
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.34
- P/E Growth: 0.00
- Market Cap: $8.69M
- Outstanding Shares: 7,065,000
- Beta: 0.29
- Net Margins: -532.94%
- Return on Equity: -356.46%
- Return on Assets: -77.79%
Companies Related to HTG Molecular Diagnostics:
- Debt-to-Equity Ratio: -3.12%
- Current Ratio: 1.99%
- Quick Ratio: 1.80%
What is HTG Molecular Diagnostics' stock symbol?
HTG Molecular Diagnostics trades on the NASDAQ under the ticker symbol "HTGM."
Where is HTG Molecular Diagnostics' stock going? Where will HTG Molecular Diagnostics' stock price be in 2017?
4 brokerages have issued 1 year target prices for HTG Molecular Diagnostics' shares. Their predictions range from $5.00 to $6.00. On average, they anticipate HTG Molecular Diagnostics' stock price to reach $5.25 in the next twelve months.
When will HTG Molecular Diagnostics announce their earnings?
HTG Molecular Diagnostics is scheduled to release their next quarterly earnings announcement on Wednesday, March, 22nd 2017.
What are analysts saying about HTG Molecular Diagnostics stock?
Here are some recent quotes from research analysts about HTG Molecular Diagnostics stock:
According to Zacks Investment Research, "HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona. " (1/17/2017)
Canaccord Genuity analysts commented, "We expect HTG will continue to announce similar collaboration agreements with pharma customers as it eventually evolves into a clinical diagnostics-focused company." (5/13/2016)
Who owns HTG Molecular Diagnostics stock?
HTG Molecular Diagnostics' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Novo A S (18.12%), FMR LLC (9.53%), Putnam Investments LLC (8.09%) and Renaissance Technologies LLC (0.82%). Company insiders that own HTG Molecular Diagnostics stock include A/S Novo, Debra A Gordon, John L Lubniewski, Patrick C Roche, Shaun D Mcmeans and Tim B Johnson.
Who bought HTG Molecular Diagnostics stock? Who is buying HTG Molecular Diagnostics stock?
HTG Molecular Diagnostics' stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Putnam Investments LLC. Company insiders that have bought HTG Molecular Diagnostics stock in the last two years include A/S Novo, Debra A Gordon, John L Lubniewski and Patrick C Roche.
How do I buy HTG Molecular Diagnostics stock?
Shares of HTG Molecular Diagnostics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of HTG Molecular Diagnostics stock cost?
One share of HTG Molecular Diagnostics stock can currently be purchased for approximately $3.18.